According to C&D's announcement, net profit for the first half of 2026 is expected to be 140 million yuan to 160 million yuan, an increase of 2.16% to 16.76% over the previous year. During the reporting period, the company actively responded to market changes, continued to promote business structure optimization and market expansion, and maintained rapid development in the distribution business and intensive medical consumables operation business, which led to a year-on-year increase in the company's overall gross profit level. Affected by changes in asset quality and inventory impairment factors, the company's asset impairment losses decreased compared to the same period last year, further improving the company's profit level.

According to C&D's announcement, net profit for the first half of 2026 is expected to be 140 million yuan to 160 million yuan, an increase of 2.16% to 16.76% over the previous year. During the reporting period, the company actively responded to market changes, continued to promote business structure optimization and market expansion, and maintained rapid development in the distribution business and intensive medical consumables operation business, which led to a year-on-year increase in the company's overall gross profit level. Affected by changes in asset quality and inventory impairment factors, the company's asset impairment losses decreased compared to the same period last year, further improving the company's profit level.